Benefit of Eculizumab for a Broad Range of Patients with Aquaporin-4 Antibody-positive Neuromyelitis Optica Spectrum Disorder: Findings from the Phase 3 PREVENT Study (1299)
Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available